View older revisions Content changed at 2025-01-25, 1403/11/06

Protocol summary

Study aim
Determining the effect of capsules containing rice bran oil and fucoxanthin on lipid profile, inflammatory factors and clinical cardiovascular indicators in patients with coronary heart disease.
Design
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 50 patients. The website http://www.randomization.com will be used for randomization.
Settings and conduct
Patients referred to Heshmat hospital, Rasht were randomly allocated into two intervention groups ( receiving a standard diet containing olive oil as the main fat source + consuming three capsules of rice bran oil and fucoxanthin daily) and control (receiving a standard diet containing olive oil as the main fat source + consuming three placebo capsules) will be included in the study. This study is double-blind and since the capsules containing rice bran oil and fucoxanthin and placebo will be completely similar to each other, and the patients receiving and the researchers providing the supplements will be blinded to the type of supplement.
Participants/Inclusion and exclusion criteria
The inclusion criteria: coronary artery blockage, no use of supplements, no history of kidney disease, no current consumption of alcohol. The exclusion criteria: change in the treatment plan and the type of effective drugs used in the study, unwillingness to continue the study or any dissatisfaction with the taste of the oil, etc.
Intervention groups
Intervention group: receiving standard diet + consuming three capsules of rice bran oil and fucoxanthin daily for 12 weeks Control group: receiving a standard diet + taking three placebo capsules daily for 12 weeks
Main outcome variables
lipid profile, fasting blood sugar level, inflammatory and antioxidant markers, and left ventricular ejection fraction

General information

Reason for update
Due to observing beneficial effects and no side effects from administering 30 grams per day of rice bran oil and 1 gram per day of rice bran oil capsules in previous clinical trial projects of the current group (whose articles have been published), it has been decided in this study to increase the amount of oil to 3 grams per day.
Acronym
IRCT registration information
IRCT registration number: IRCT20240717062445N1
Registration date: 2024-07-23, 1403/05/02
Registration timing: prospective

Last update: 2025-01-25, 1403/11/06
Update count: 1
Registration date
2024-07-23, 1403/05/02
Registrant information
Name
Marjan Mahdavi roshan
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 13 3361 9177
Email address
marjanmahdavi60@gmail.com
Recruitment status
recruiting
Funding source
Expected recruitment start date
2025-02-27, 1403/12/09
Expected recruitment end date
2026-02-28, 1404/12/09
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effects of a supplement containing rice bran oil and fucoxanthin on lipid profile, inflammatory indicators, and clinical and biochemical cardiovascular parameters in patients with coronary artery disease: A randomized clinical trial
Public title
Capsules containing rice bran oil and fucoxanthin in patients with coronary heart disease
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age range 20 to 70 years Not using vitamin and mineral supplements, antioxidants, fiber supplements, omega-3 No history of kidney disease, no current alcohol consumption Coronary artery occlusion diagnosed by angiography by a cardiologist. No current consumption of alcoholic beverages
Exclusion criteria:
Changes in the patient's coronary disease treatment plan during the study Changing the type of drugs used, effective factors studied Creating any kind of dissatisfaction in the field of oil taste and...
Age
From 20 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
Sample size
Target sample size: 50
Randomization (investigator's opinion)
Randomized
Randomization description
The method of sampling and randomization of this two parallel double-blind clinical trial study, will be using the stratified block randomization method. At first, the participants will be classified into two groups according to their age (20 to 45 years and between 45 to 70 years), and then each person will randomly assigned to the intervention or control group using blocks of 4 randomly at a ratio of 1:1. One of the letters A or B will be assigned to each group.For randomization, the website http://www.randomization.com/ will be used. The list of codes obtained from this website will be provided to the researchers, and every referring patient who meets the inclusion criteria and does not meet the exclusion criteria and is willing to participate in the research, is first entered in the desired age group and in order Based on the assigned code, A or B enters the plan
Blinding (investigator's opinion)
Double blinded
Blinding description
Since the capsules containing rice bran oil and fucoxanthin and placebo have been tried to be completely similar to each other due to the similarity in taste, aroma and smell, the patients receiving and the researchers providing the supplements of the type of supplement that each participant receives will not find awareness.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research and Technology Vice-Chancellor of Guilan University of Medical Sciences
Street address
Namjoo Blvd, Rasht City, Guilan province, Iran
City
Rasht
Province
Guilan
Postal code
41887-94755
Approval date
2024-06-26, 1403/04/06
Ethics committee reference number
IR.GUMS.REC.1403.154

Health conditions studied

1

Description of health condition studied
Coronary artery disease
ICD-10 code
I25.1
ICD-10 code description
Atherosclerotic heart disease of native coronary artery

Primary outcomes

1

Description
Serum lipid profile levels (triglycerides, total cholesterol, LDL-C and HDL-C)
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
BT2000 device

2

Description
Fasting blood sugar
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
BT2000 device

3

Description
Serum insulin
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
BT2000 device

4

Description
Glycosylated hemoglobin
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

5

Description
Erythrocyte sedimentation rate
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

6

Description
Glutathione peroxidase activity
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

7

Description
Glutathione reductase activity
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

8

Description
Vitamin E
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

9

Description
HS - C-reactive protein
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
ELISA device

Secondary outcomes

1

Description
Mean systolic and diastolic blood pressure
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
Pressure indicator

2

Description
Body mass index
Timepoint
At the beginning of the study and 12 weeks later
Method of measurement
Centimeter and scales

Intervention groups

1

Description
Intervention group: receiving a standard diet containing olive oil as the main fat source + consuming three capsules of rice bran oil produced by Giltaz company and fucoxanthin produced by Danesh Bonyan Algae Bank company (daily) for 12 weeks with lunch
Category
Treatment - Drugs

2

Description
Control group: receiving a standard diet containing olive oil as the main fat source+ taking three placebo capsules produced by Barij Essence Company for 12 weeks along with lunch. The placebo capsule contains paraffin. The placebo will be completely similar to the capsule of the intervention group in terms of shape, color and smell, and they will be placed in cans of the same shape and color.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Dr. Heshmat Rasht Hospital
Full name of responsible person
Marjan Mahdavi Roshan
Street address
Dr. Heshmat Hospital; Bayani St; Mosala Square; Rasht.
City
Rasht
Province
Guilan
Postal code
4193955588
Phone
+98 13 3366 8718
Email
marjanmahdavi60@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Ramyar Farzan
Street address
Gulan Province, Saravan Rd, Guilan Academic Complex of Medical Science, Saravan road, Guilan, Iran.
City
Rasht
Province
Guilan
Postal code
1333668718
Phone
+98 13 3348 6407
Email
marjanmahdavi60@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Rasht University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Marjan Mahdavi Roshan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Guilan Academic Complex of Medical Sciences, Saravan Rd, Guilan Province, Iran
City
Rasht
Province
Guilan
Postal code
4193955588
Phone
+98 13 3348 6407
Email
marjanmahdavi60@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Marjan Mahdavi Roshan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Guilan Academic Complex of Medical Sciences, Saravan Rd, Guilan Province, Iran
City
Rasht
Province
Guilan
Postal code
41887-94755
Phone
+98 13 3334 6649
Email
marjanmahdavi60@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Marjan Mahdavi Roshan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Guilan Academic Complex of Medical Sciences, Saravan Rd, Guilan Province, Iran
City
Rasht
Province
Guilan
Postal code
41887-94755
Phone
+98 13 3334 6649
Email
marjanmahdavi60@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...